AMS - American Shared Hospital Services Inc Prognoz qilingan narxning foydaga nisbati

American Shared Hospital Services (AMS) kompaniyasining korporativ logotipi

Kontraktlar uchun kuchli raqobat va klinikalarning bevosita xarid qilish xavfi American Shared Hospital (AMS) kompaniyasining kelgusidagi NTM P/E ko'rsatkichiga salbiy ta'sir ko'rsatib, tebranishlarni keltirib chiqarmoqda. Fundamental ko'rsatkichlar shifoxonalarning Gamma Knife tizimiga bo'lgan ishonchi va uskunalarni moslashuvchan lizingga berish orqali mijozlar bazasini kengaytirishga tayanadi. 0.00 qiymati ushbu ko'rsatkichning joriy miqdorini ko'rsatib, aksiyaning kutilayotgan foyda darajasiga nisbatan qanchalik hadda qimmat baholanganligini baholash imkonini beradi.

AMS - American Shared Hospital Services Forvard P/E multiplikatori 04.07.2022 - 12.11.2026 oraligʻida

ASHS (AMS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

American Shared Hospital brendining mahsuloti

American Shared Hospital (AMS) tomonidan radiatsiya terapiyasi to'lovlaridan olingan barqaror daromad, kompaniyaning forward P/E NTM ko'rsatkichi orqali joriy kapitalizatsiyaning keyingi yilgi kutilayotgan foydasi bilan qanchalik mos kelishini baholash imkonini beradi. Ushbu ko'rsatkich kelajakdagi pul oqimlari bo'yicha bozor optimizmini o'lchaydi va uskunalarning uzoq muddatli qoplash sikllarini hisobga olgan holda, investorlarga aktiv haddan tashqari sotib olinganini aniqlash yoki kirish nuqtasini belgilashda yordam beradi.

Asosiy raqobatchilar

Kelajakdagi narxning foydaga nisbati HCA Healthcare, Inc. (HCA)|Tenet Healthcare Corp - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati SOLV (Solventum Health)|Encompass Health - Forvard P/E multiplikatori|UHS - Forvard P/E multiplikatori|DaVita (DVA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati RadNet Inc|OPCH (Option Care Health Inc) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Surgery Partners Group SGRY|Kelajakdagi narxning foydaga nisbati Premier, Inc. (PINC)|EYE (nationalvision.com) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori PGNY (Progyny)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Ardent Health (ARDT)|Select Medical Corp - Forvard P/E multiplikatori|Astrana Corp (ASTH) - Prognoz qilingan narxning foydaga nisbati|MD: Forvard P/E multiplikatori|U.S. Physical Therapy, Inc. (USPH) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati The Pennant Group|Narxning kelajakdagi foydaga nisbati ORGO (Organogenesis Holdings Inc.)|Prognoz qilingan narxning foydaga nisbati NUTX (Nutex Health Corp)|AUNA (Auna Corp) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati SBC Medical Group Holdings Inc SBC|Kapitalizatsiyaning prognoz qilingan foydaga nisbati evolus.com (EOLS)|Community Health Systems, Inc. - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori SKIN (The Beauty Health)|MDWD: Forvard P/E multiplikatori|Biote Corporation (BTMD) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati The Joint Corp.|DCGO: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori PIII|GANX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori EUDA (EUDA Health)|BMGL: Narxning kelajakdagi foydaga nisbati|CLGN: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CUPR (cuprina.com.sg)|CCM: Forvard P/E multiplikatori|MEDIROM Healthcare Group Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Avalon GloboCare Corp|Prognoz qilingan narx-foyda nisbati DIH Group DHAI|Kelajakdagi narxning foydaga nisbati Longevity Health Holdings (XAGE)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati newgenivf.com|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy, Inc. ATIP|CMAX (CareMax Inc.) - Narxning kutilayotgan foydaga nisbati|Kindly MD Corp - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati ModivCare Corp MODV|NVOS (Novo Integrated Sciences) - Prognoz qilingan narxning foydaga nisbati|SSY: Kapitalizatsiyaning kelajakdagi foydaga nisbati|BACK (IMAC Holdings) - Forvard P/E multiplikatori